Ubs Global Asset Management Americas »

Aeglea Biotherapeutics shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.1M 49k 23.28
2024-09-30 $778k 26k 29.41
2024-06-30 $708k 30k 23.51